Independent Research analyst Tobias Gottschalt maintained a Hold rating on Siemens Healthineers AG (SEMHF – Research Report) today and set a price target of EUR51.00. The company’s shares closed last Tuesday at $57.95, close to its 52-week high of $60.50.
According to TipRanks.com, Gottschalt is ranked #6642 out of 7491 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Siemens Healthineers AG with a $62.98 average price target, an 8.7% upside from current levels. In a report issued on April 29, Barclays also maintained a Hold rating on the stock with a EUR47.00 price target.
The company has a one-year high of $60.50 and a one-year low of $42.75. Currently, Siemens Healthineers AG has an average volume of 475.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Erlangen, Germany.